Iron supplementation for patients undergoing cardiac surgery: a systematic review and meta-analysis of randomized controlled trials;Supplémentation en fer pour les patients bénéficiant d’une chirurgie cardiaque : une revue systématique et une méta-analyse d’études randomisées contrôlées

Canadian Journal of Anesthesia

Volumn 69, Issue 1, 2022, Pages 129-139

  Yang, Stephen Su ^a,b   Al Kharusi, Latifa ^a   Gosselin, Adam ^a   Chirico, Anissa ^a   Baradari, Pouya Gholipour ^a   Cameron, Matthew J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Anemia; Blood transfusion; Cardiac surgery; Iron

Indexed keywords

HEMOGLOBIN; IRON;

ANEMIA; CARDIOPULMONARY BYPASS; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS SURGERY; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEART VALVE SURGERY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RETICULOCYTE COUNT; REVIEW; SYSTEMATIC REVIEW; ADULT; DIETARY SUPPLEMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; ANEMIA; CARDIAC SURGICAL PROCEDURES; DIETARY SUPPLEMENTS; HUMANS; IRON; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85115620055     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-021-02113-z     Document Type: Review

References (37)

1. Hung M, Besser M, Sharples LD, Nair SK, Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011; 66: 812-8. DOI: 10.1111/j.1365-2044.2011.06819.x
2. Gulack BC, Kirkwood KA, Shi W, et al. Secondary surgical-site infection after coronary artery bypass grafting: a multi-institutional prospective cohort study. J Thorac Cardiovasc Surg 2018; 155: 1555-62.e1. DOI: 10.1016/j.jtcvs.2017.10.078
3. Cutrell JB, Barros N, McBroom M, et al. Risk factors for deep sternal wound infection after cardiac surgery: influence of red blood cell transfusions and chronic infection. Am J Infect Control 2016; 44: 1302-9. DOI: 10.1016/j.ajic.2016.03.027
4. Likosky DS, Paone G, Zhang M, et al. Red blood cell transfusions impact pneumonia rates after coronary artery bypass grafting. Ann Thorac Surg 2015; 100: 794-800; discussion 801.
5. Alameddine AK, Visintainer P, Alimov VK, Rousou JA. Blood transfusion and the risk of atrial fibrillation after cardiac surgery. J Card Surg 2014; 29: 593-9. DOI: 10.1111/jocs.12383
6. Engoren M, Schwann TA, Jewell E, et al. Is transfusion associated with graft occlusion after cardiac operations? Ann Thorac Surg 2015; 99: 502-8. DOI: 10.1016/j.athoracsur.2014.09.028
7. Tantawy H, Li A, Dai F, et al. Association of red blood cell transfusion and short- and longer-term mortality after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2018; 32: 1225-32. DOI: 10.1053/j.jvca.2017.12.033
8. LaPar DJ, Hawkins RB, McMurry TL, et al. Preoperative anemia versus blood transfusion: which is the culprit for worse outcomes in cardiac surgery? J Thorac Cardiovasc Surg 2018; 156: 66-74.e2. DOI: 10.1016/j.jtcvs.2018.03.109
9. Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017; 377: 2133-44. DOI: 10.1056/NEJMoa1711818
10. Patel KV. Epidemiology of anemia in older adults. Semin Hematol 2008; 45: 210-7. DOI: 10.1053/j.seminhematol.2008.06.006
11. Rössler J, Schoenrath F, Seifert B, et al. Iron deficiency is associated with higher mortality in patients undergoing cardiac surgery: a prospective study. Br J Anaesth 2020; 124: 25-34. DOI: 10.1016/j.bja.2019.09.016
12. Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996; 27: 234-8. DOI: 10.1016/S0272-6386(96)90546-6
13. Xu H, Duan Y, Yuan X, Wu H, Sun H, Ji H. Intravenous iron versus placebo in the management of postoperative functional iron deficiency anemia in patients undergoing cardiac valvular surgery: a prospective, single-blinded, randomized controlled trial. J Cardiothorac Vasc Anesth 2019; 33: 2941-8. DOI: 10.1053/j.jvca.2019.01.063
14. Spahn DR, Schoenrath F, Spahn GH, et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial. Lancet 2019; 393: 2201-12. DOI: 10.1016/S0140-6736(18)32555-8
15. Lee SH, Shim JK, Soh S, et al. The effect of perioperative intravenously administered iron isomaltoside 1000 (Monofer®) on transfusion requirements for patients undergoing complex valvular heart surgery: study protocol for a randomized controlled trial. Trials 2018; DOI: 10.1186/s13063-018-2545-3. DOI: 10.1186/s13063-018-2545-3
16. Koch TA, Myers J, Goodnough LT. Intravenous iron therapy in patients with iron deficiency anemia: dosing considerations. Anemia 2015; DOI: 10.1155/2015/763576. DOI: 10.1155/2015/763576
17. Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang 2015; 109: 257-66. DOI: 10.1111/vox.12278
18. Schack A, Berkfors AA, Ekeloef S, Gögenur I, Burcharth J. The effect of perioperative iron therapy in acute major non-cardiac surgery on allogenic blood transfusion and postoperative haemoglobin levels: a systematic review and meta-analysis. World J Surg 2019; 43: 1677-91. DOI: 10.1007/s00268-019-04971-7
19. Ng O, Keeler BD, Mishra A, et al. Iron therapy for preoperative anaemia. Cochrane Database Syst Rev 2019; DOI: 10.1002/14651858.CD011588.pub3. DOI: 10.1002/14651858.CD011588.pub3
20. Engelman DT, Ben Ali W, Williams JB, et al. Guidelines for perioperative care in cardiac surgery: enhanced recovery after surgery society recommendations. JAMA Surg 2019; 154: 755-66. DOI: 10.1001/jamasurg.2019.1153
21. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; DOI: 10.1371/journal.pmed.1000097.
22. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev 2016; DOI: 10.1186/s13643-016-0384-4. DOI: 10.1186/s13643-016-0384-4
23. Sterne JA, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; DOI: 10.1136/bmj.l4898. DOI: 10.1136/bmj.l4898
24. Guyatt GH, Oxman AD, Kunz R, et al. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336: 995-8. DOI: 10.1136/bmj.39490.551019.BE
25. Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol 2017; DOI: 10.1186/s12874-017-0315-7. DOI: 10.1186/s12874-017-0315-7
26. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014; DOI: 10.1186/1471-2288-14-135. DOI: 10.1186/1471-2288-14-135
27. Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary artery bypass surgery: a randomized, placebo-controlled study. Heart Lung 1994; 23: 493-9.
28. Garrido-Martín P, Nassar-Mansur MI, de la Llana-Ducrós R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg 2012; 15: 1013-8. DOI: 10.1093/icvts/ivs344
29. Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18: 59-63. DOI: 10.1053/j.jvca.2003.10.012
30. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 2015; DOI: 10.1371/journal.pone.0117383. DOI: 10.1371/journal.pone.0117383
31. Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol 2013; 88: 97-101. DOI: 10.1002/ajh.23354
32. Richards T, Baikady RR, Clevenger B, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet 2020; 396: 1353-61. DOI: 10.1016/S0140-6736(20)31539-7
33. Garcia-Alamino JM, Bankhead C, Heneghan C, Pidduck N, Perera R. Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses. BMJ Open 2017; DOI: 10.1136/bmjopen-2017-015888. DOI: 10.1136/bmjopen-2017-015888
34. Rössler J, Hegemann I, Schoenrath F, et al. Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial. Anaesthesia 2020; 75: 1039-49. DOI: 10.1111/anae.15062
35. Kei T, Mistry N, Curley G, et al. Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis. Can J Anesth 2019; 66: 716-31. DOI: 10.1007/s12630-019-01351-6
36. Cho BC, Serini J, Zorrilla-Vaca A, et al. Impact of preoperative erythropoietin on allogeneic blood transfusions in surgical patients: results from a systematic review and meta-analysis. Anesth Analg 2019; 128: 981-92. DOI: 10.1213/ANE.0000000000004005
37. Hare GM, Mazer CD. Anemia: perioperative risk and treatment opportunity. Anesthesiology 2021; DOI: 10.1097/ALN.0000000000003870. DOI: 10.1097/ALN.0000000000003870